Canada Spends Logo

Explore our Budget 2026 analysis

Contribution: Regional Economic Growth through Innovation

Augurex Life Sciences Corp.

$5,000,000.00

PC0007104

FY 2023-24 · 2024-01-15

Summary
Commercialize autoantibody test for early detection and monitoring of autoimmune diseases
Program
Regional Economic Growth through Innovation
Location
Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
829919521
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions

As published

Agreement End Date
2027-03-31
Agreement Number
PC0007104
Agreement Start Date
2024-01-15
Agreement Title
PC0007104
Agreement Title (French)
PC0007104
Agreement Type
Contribution
Agreement Value
$5,000,000.00
Amendment Number
0
Description
Commercialize autoantibody test for early detection and monitoring of autoimmune diseases
Description (French)
Commercialiser un test d’autoanticorps pour la détection précoce et le suivi des maladies auto-immunes
Expected Results
539 Expected results not defined
Expected Results (French)
539 Expected results not defined
Federal Riding
Vancouver East
Federal Riding (French)
Vancouver-Est
Federal Riding Number
35
NAICS Code
541710
Organization Code
pacifican
Organization
Pacific Economic Development Canada | Développement économique Canada pour le Pacifique
Program Name
Regional Economic Growth through Innovation
Program Name (French)
Croissance économique régionale par l'innovation
Program Purpose
Provide streamlined, nationally consistent and yet regionally tailored support for business productivity and scale-up, particularly for small and medium-sized enterprises (SMEs) and women entrepreneurs and other underrepresented groups, and assist the enhancement of regional industrial and technology clusters and regional innovation ecosystems.
Program Purpose (French)
Fournir un soutien simplifié uniforme à l'échelle nationale mais adapté à l'échelle régionale pour la productivité et la croissance des entreprises, particulièrement au profit des petites et moyennes entreprises (PME) et des femmes entrepreneurs et autres groupes sous-représentés, et contribuer à l'amélioration des grappes industrielles et technologiques régionales et des écosystèmes d'innovation régionaux.
Recipient Business Number
829919521
Recipient City
Vancouver
Recipient Country
CA
Recipient Legal Name
Augurex Life Sciences Corp.
Recipient Operating Name
Augurex Life Sciences Corp
Recipient Postal Code
V5T 4T5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
GC-WD-DEO-2023-2024-Q4-61